Search All Funding News

Filter NIAID Funding News by year:
2025 | 2024 | 2023

182 Results

“Is there a tutorial for using NIH RePORTER?”

Funding News Edition: September 20, 2023

Share Your Views on Proposed Revisions to Biosafety Policy

Funding News Edition: September 20, 2023

Respond to a request for information on Potential Changes to the Policies for Oversight of Dual Use Research of Concern and the Potential Pandemic Pathogen Care and Oversight Policy Framework by October 16, 2023.

“What does basic research mean?”

Funding News Edition: February 15, 2023

Generate Your Own Lists of Recently Funded Grants

Funding News Edition: March 16, 2023

You can create a list of recently funded NIAID grant awards to better assess the direction of preferences and priorities for NIAID peer reviewers and program staff.

Bookmark New Resource for Guidance Should You Need to Report a Concern

Funding News Edition: May 3, 2023

There are several types of concerns a researcher might need to report to NIH during the application process or while conducting NIH-supported research, from grant scams to research misconduct to peer-review integrity violations.

Extended Deadline for Characterization of HIV Vaccine Formulations BAA

Funding News Edition: May 3, 2023

NIAID has extended the application deadline for the broad agency announcement (BAA) Rational Systematic Characterization and Selection of Adjuvants for HIV Vaccine Candidates; proposals are now due on July 7, 2023, at 4 p.m. Eastern Time.

Summary of January 2023 Advisory Council Meeting

Funding News Edition: February 15, 2023

NIAID Acting Director Dr. Hugh Auchincloss provided updates on HIV/AIDS, malaria, Ebola, a promising Marburg vaccine, universal flu vaccine efforts, non-viral asthma attacks, monoclonal antibodies to target Epstein-Barr virus, and human antibody response to vaccinations.

News Briefs and Worth Repeating

Funding News Edition: August 16, 2023

Dr. Jeanne Marrazzo Selected as NIAID’s Next Director; Collaborate with the AIDS Clinical Trials Group on HIV Remission and Cure; Stream Scientific Meeting on Congenital Cytomegalovirus Vaccine Research

Human Subjects System—Quick Guide for Warnings and Errors

Funding News Edition: June 21, 2023

A new resource from eRA describes red flags that users commonly encounter when using the Human Subjects System to report, view, and update a project’s human subjects enrollment, inclusion, and clinical trial data.

Caveats to Consider Before Preaward Spending

Funding News Edition: September 20, 2023

You may ask your institutional business office for preaward spending approval to cover costs up to 90 days before the start date of the initial budget period of a new or renewal award.

NIAID Paylines and Budget Data Updates from March 2023

Funding News Edition: April 5, 2023

Use the Budget Data Comparisons table to compare the enacted funding levels for fiscal years 2022 and 2023 across multiple NIH institutes and centers, including NIAID. 

New Solicitation Focuses on Development of Cellular Immunology Core

Funding News Edition: January 18, 2023

NIAID seeks a partner to operate the Cellular Immunology Core Laboratory, which will conduct, analyze, develop, optimize, and validate cellular immunologic assays for multiple pathogens, to be performed on fresh and frozen preclinical samples.

Find the Right Person to Help You with General Inquiries

Funding News Edition: November 8, 2023

Whom should you ask for help with general matters like identifying an appropriate funding opportunity or discovering available resources?

Minimum Performance Standards, Tax Deductions for Small Business Awardees

Funding News Edition: April 5, 2023

Federal income/excess profits taxes are strictly not allowable charges to NIH awards, either as direct or facilities and administrative costs. However, the small business fee may be used to pay for a tax liability.

There’s More to Biosafety and Biosecurity Than Select Agents

Funding News Edition: May 3, 2023

Review key terminology like dual use research of concern, enhanced potential pandemic pathogens, select agents, and recombinant or synthetic nucleic acid molecules.

Highlights from June’s Advisory Council Meeting

Funding News Edition: June 21, 2023

NIAID Acting Director Dr. Hugh Auchincloss discussed administrative, budget, and legislative updates, as well as recent scientific findings. Then Dr. Steven Holland, Director of NIAID’s Division of Intramural Research, described key research accomplishments at our intramural laboratories.

A Summary of Outcomes from Our September Advisory Council Meeting

Funding News Edition: October 4, 2023

NIAID Acting Director Dr. Hugh Auchincloss provided remarks on the Institute’s administrative, budget, and scientific news. He was followed by guest speaker Dr. Ted Pierson, Director of NIAID’s Vaccine Research Center, who discussed recent scientific advances and ongoing research priorities.

NIH Announces Revisions to NIH Grants Policy Statement for Fiscal Year 2023

Funding News Edition: January 18, 2023

The NIH Grants Policy Statement provides up-to-date policy instruction that serves as the standard terms and conditions of award for NIH grants, as well as guidance for applicants pursuing an NIH grant.

Non-Discrimination Requirements in All New Grant Opportunities and Awards

Funding News Edition: January 18, 2023

HHS offers guidance on how to administer your program in compliance with applicable Civil Rights laws, e.g., sex discrimination and harassment, disability, and religious freedom.

Contact Us

Email us at deaweb@niaid.nih.gov for help navigating NIAID’s grant and contract policies and procedures.